Content about Pharmaceutical industry

NORTH WALES, Pa. Teva Pharmaceuticals has launched a generic treatment for epileptic seizures.

The world’s largest generic drug maker announced Wednesday the launch of diazepam rectal gel, a generic version of Valeant Pharmaceuticals’ Diastat AcuDial. The drug is administered via rectal syringe and is available in 2.5-mg, 10-mg and 20-mg strengths.

MUMBAI, India A generic drug maker has received regulatory approval for its version of an attention deficit hyperactivity disorder treatment.

Sun Pharmaceutical Industries' subsidiary has received approval to market its generic version of Strattera (atomoxetine hydrochloride capsules), an ADHD drug for children ages 6 years and older, as well as teens and adults. Strattera is made and marketed by Eli Lilly.

Annual sales of branded and generic atomoxetine hydrochloride capsules are estimated to be more than $530 million.

CAMBRIDGE, Mass. After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday, Genzyme said "the identical offer ... fails to establish a basis for engagement by the Genzyme board."

Sanofi-Aventis offered to acquire Genzyme for $69 per share in cash on two occasions. Prior to Monday's duplicate offer, the first offer was sent to Genzyme on July 29. The drug maker rejected the offer two weeks later.

FOSTER CITY, Calif. A generic drug maker has filed an abbreviated new drug application for its version of a Gilead Sciences drug.

FOSTER CITY, Calif. A generic drug maker has filed an abbreviated new drug application for its version of a Gilead Sciences drug.

BRISTOL, Tenn. Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing, managed care, sales operations and business analytics for the drug maker.

BRISTOL, Tenn. Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing, managed care, sales operations and business analytics for the drug maker.

HAUPPAUGE, N.Y. The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis made by Amneal Pharmaceuticals, Amneal said Thursday.

The FDA approved Amneal’s spironolactone hydrochloride tablets in the 25 mg, 50 mg and 100 mg strengths. The drug is a generic version of Pfizer’s Aldactone. Various versions of the drug had sales of $91 million in 2009, according to IMS Health.

NEW YORK Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in patients with advanced non-small cell lung cancer.

The drug maker said the combination of Pfizer’s Sutent (sunitinib) and Tarceva (erlotinib), made by Genentech and OSI Pharmaceuticals, kept the disease from progressing, but did not improve patients’ overall survival, which was the trial’s primary goal. The company expects to present results at the European Society for Medical Oncology Congress in Milan in October.

NORTH WALES, Pa. Teva Pharmaceutical Industries has launched a generic version of a weekly formulation of a popular antidepressant, the generic drug maker said.

Teva announced the launch of fluoxetine delayed-release capsules, a generic version of Eli Lilly’s Prozac Weekly.

NORTH WALES, Pa. Teva Pharmaceutical Industries has launched a generic version of a weekly formulation of a popular antidepressant, the generic drug maker said.

NORTH WALES, Pa. Teva Pharmaceutical Industries has introduced a generic drug for lowering patients’ blood pressure, the world’s largest manufacturer of generic drugs said Monday.

Teva introduced clonidine transdermal system, a generic version of Boehringer Ingelheim’s Catapres-TTS. The drug is available in 0.1 mg, 0.2 mg and 0.3 mg strengths and comes in the form of a patch designed for daily application.

The drug has annual sales of around $297 million, according to IMS Health.